Bridgewest Group
Overview
Bridgewest Group is a privately held global investment firm with over $3 billion in private capital, focusing on empowering people through business investment. The firm has a 25-year history of building transformative businesses across life sciences, software, semiconductors, and advanced manufacturing. With a presence in the United States, Australia, New Zealand, and Asia, Bridgewest Group actively partners with founders, governments, and research institutions to unlock high-growth opportunities and accelerate innovation. The firm's portfolio includes over 40 companies spanning sectors critical to the future of healthcare and technology, including AI, biologics manufacturing, gene therapy, drug development, cloud infrastructure, and 5G innovation. Bridgewest Group also manages a significant real estate and fixed income portfolio, including commercial properties, development projects, and tailored credit strategies that generate stable returns. The firm's robust eco-community, including its Global Capability Center - Bridgewest India, facilitates functional support so CEOs can turn their ideas into prosperous companies. Nearly 100% of portfolio CEOs stay with Bridgewest Group to form new ventures after exits. The firm's investment strategy emphasizes people empowerment, collaborative mentorship, and capital infusion to move the brightest entrepreneurs forward, from idea inception through exit. As private investors, Bridgewest Group is not beholden to other investors nor artificial timeframes, allowing them to maximize outcomes for everyone based on merit instead of timeline adherence. The firm's operating partners and subject matter experts guide entrepreneurs to successful financial outcomes, providing deep operational support—from capital markets and legal structuring to product strategy and executive mentoring—ensuring each venture has the tools and guidance to scale sustainably. Notable achievements include launching BioDuro (now the world’s third-largest CRDMO), acquiring and transforming Pfizer’s Australian facilities into leading CDMO BioCina, and engineering successful exits such as RapidBridge to Qualcomm and Wavious to a Fortune 5 tech company. Bridgewest Group's life's work has empowered people and ideas to thrive, working with industry leaders like AT&T, Advent International, Intel, Pfizer, Qualcomm, and Verizon, driving billion-dollar exits and building lasting legacies.
Investment Focus
- Innovative companies in technology and healthcare sectors seeking capital and strategic support
Portfolio Companies
Reach Bridgewest Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bridgewest Group
What sectors does Bridgewest Group invest in?
Bridgewest Group invests in Financial Services, Technology, Healthcare, Real Estate, Software and Artificial Intelligence, and is based in San Diego, California, United States. Bridgewest Group is listed as a private investment firm in the ConnectSafely investor database.
What stage does Bridgewest Group invest at?
Bridgewest Group backs companies at Seed, Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.
Which regions does Bridgewest Group invest in?
Bridgewest Group invests across United States, Australia, China, India and New Zealand.
Who are the partners at Bridgewest Group?
Team members listed for Bridgewest Group include Adam Gickling (Executive Vice President and Global Chief Operating Officer) and Alexander Kimmet (Chief of Staff and Operating Partner).
What companies has Bridgewest Group invested in?
Bridgewest Group's portfolio includes Projectworks, BioDuro, BioCina, RapidBridge and Wavious.
How do I contact Bridgewest Group?
Bridgewest Group's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
